Ditchcarbon
  • Customers
  1. Organizations
  2. Stallergenes Greer Ltd
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 6 months ago

Stallergenes Greer Ltd

Company website

Stallergenes Greer Ltd, a leading player in the immunotherapy industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2014 through the merger of Stallergenes and Greer Laboratories, the company has quickly established itself as a pioneer in allergy treatment solutions. Specialising in allergen immunotherapy, Stallergenes Greer offers a range of innovative products, including sublingual and injectable therapies, designed to provide long-term relief from allergic conditions. Their commitment to research and development has led to significant advancements in personalised treatment options, setting them apart in a competitive market. With a strong focus on patient-centric care, Stallergenes Greer Ltd has achieved notable recognition for its contributions to allergy management, solidifying its position as a trusted name in the field.

DitchCarbon Score

How does Stallergenes Greer Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Stallergenes Greer Ltd's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Stallergenes Greer Ltd's reported carbon emissions

Stallergenes Greer Ltd, headquartered in Great Britain, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As a result, there are no specific initiatives or commitments to report regarding their carbon footprint or climate action strategies. The absence of emissions data and reduction initiatives suggests that Stallergenes Greer Ltd may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific data or commitments from Stallergenes Greer Ltd, it is challenging to assess their position relative to industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Stallergenes Greer Ltd's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Stallergenes Greer Ltd is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Stallergenes Greer Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Vimian

SE
•
Health and social work services (85)
Updated about 8 hours ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy